Reliability and Validity of Patient Self-reported Daily Questionnaire on Oral Mucositis in Acute Leukemic Patients under Chemotherapy

화학요법을 받는 급성백혈병 환자 자가보고형 구강점막염 사정도구의 신뢰도와 타당도 분석

  • Received : 2010.10.25
  • Accepted : 2010.12.10
  • Published : 2010.12.31

Abstract

Purpose: Oral mucositis (OM) is a serious consequence of chemotherapy that cancer patients must undergo. The objectives of this study were to find out reliability and validity of patients self-reported daily questionnaires on OM, and the impact OM makes on daily functions. Method: To test the reliability of oral mucositis daily questionnaire (OMDQ), internal consistency of the instrument (Cronbach's ${\alpha}$ and correlation between items) and test-retest reliability were analyzed. Criterion validity and discriminative validity were evaluated using WHO, oral assessment guide, and Nicolatou assessment tool. Forty-eight acute leukemic patients under chemotherapy were enrolled in this study. Result: The Cronbach's ${\alpha}$ coefficient indicated sufficient internal consistency. Correlations of Mouth and throat soreness (MTS) and MTSActivity Limitations (MTS-AL) were statistically significant. MTS and MTS-AL scores on consecutive days were highly correlated (days13,14=.84-.96; test-retest reliability). OMDQ scale had high criterion validity and discriminative validity. Patients with more severe WHO OM grades had higher MTS mean scores. Conclusion: Oral mucositis in acute leukemic patients under going chemotherapy can be easily quantified by patient self-administered OMDQ with reliability and validity.

Keywords

References

  1. A handbook for reporting results of cancer treatment. (1979). Geneva, Switzerland, World Health Organization.
  2. Beck, S. (1979). Impact of a systematic oral care protocol on stomatitis after chemotherapy. Cancer Nursing, 2, 185-199.
  3. Bellm, L. A., Cunningham, G., Durnell, L., Eilers, J., Epstein, J. B., Fleming, T., et al. (2002). Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: Oral mucositis patient provider advisory board. Cancer Investigation, 20, 793-800. https://doi.org/10.1081/CNV-120002497
  4. Brown, C. G., & Wingard, J. (2004). Clinical consequences of oral mucositis. Seminars in oncology Nursing, 20, 16-21. https://doi.org/10.1053/j.soncn.2003.10.004
  5. Byun, Y. S., & Kim, A. K. (1996). Experimental study for construction of mouth care in chemotherapy patients. Journal of Korean Academy of Nursing, 26, 428-442.
  6. Dreizen, S. (1990). Description and incidence of oral complications. National Cancer Institute Monography, 9, 11-15.
  7. Duncan, G. G., Epstein, J. B., Tu, D., El Sayed, S., Bezjak, A., Ottaway, J. et al. (2005). Quality of life, mucositis and xerostomia from radiotherapy for head and neck cancers. A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head Neck, 27, 421-428. https://doi.org/10.1002/hed.20162
  8. Eilers, J., Berger, A. M., & Petersen, M. C. (1988). Development, testing, and application of the oral assessment guide. Oncology Nursing Forum, 15, 325-330.
  9. Eilers, J., & Epstein, J. B. (2004). Assessment and measurement of oral mucositis. Seminars in Oncology Nursing, 20, 22-29. https://doi.org/10.1053/j.soncn.2003.10.005
  10. Elting, L. S., Keefe, D. M., Sonis, S. T., Garden, A. S., Spijkervet, F. K., Barasch, A. et al. (2008). Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: Demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer, 113, 2704-2713. https://doi.org/10.1002/cncr.23898
  11. Epstein, J. B., Beaumont, J. L,. Gwede, C. K., Murphy, B., Garden, A. S., & Meredith, R. (2007). Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer, 109, 1914-1922. https://doi.org/10.1002/cncr.22620
  12. Heo, S. L., Jung, M. A., Kim, H. S., Kwon, I. K., Hong, J. H., & Park, E. Y. (2003). The effect of GM-CSF oral gargle vs traditional betadine or chlorhexidine oral gargle in chemotherapy-induced stomatitis. Journal of Korean Clinical Nursing Research, 8, 169-182.
  13. Jaroneski, L. A. (2006). The importance of assessment rating scales for chemotherapy-induced oral mucositis. Oncology Nursing Forum, 33, 1085-1090. https://doi.org/10.1188/06.ONF.1085-1093
  14. Jung, Y. Y. (1996). Reliability testing of an oral assessment guide for patients receiving stomatoxic treatment. The Seoul Journal of Nursing, 10, 45-51.
  15. Kim, Y. H., Jeon, M. H., & Choi, J. S. (1997). Prevention of chemotherapy induced oral mucositis in patients with acute leukemia by the two oral care protocols: The comparision of sodium bicarbonate normal saline gargling and chlorhexidine gargling. Journal of Korean Academy of Adult Nursing, 9, 98-111.
  16. Kushner, J. A., Lawrence, H. P., Shoval, I., Kiss, T. L., Devins, G. M., Lee, L. et al. (2008). Development and validation of a Patient-Reported Oral Mucositis Symptom (PROMS) scale. Journal of Canadian Dental Association, 74, 59.
  17. McGuire, D. B., Altomonte, V., Peterson, D. E., Wingard, J. R., Jones, R. J., & Grochow, L. B. (1993). Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncology Nursing Forum, 20, 1493-1502.
  18. Nicolatou, O., Sotiropoulou-Lontou, A., Skarlatos, J., Kyprianou, K., Kolitsi, G., & Dardoufas, K. (1998). A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: A preliminary report. International Journal of Radiation Oncology, Biology, Physcis, 42, 551-556. https://doi.org/10.1016/S0360-3016(98)00253-3
  19. Ohrn, K. E. O., Wahlin, Y. B., & Sjoden, P. O. (2001). Oral status during radiotherapy and chemotherapy: A descriptive study of patient experiences and the occurrence of oral complications. Support Care Cancer. 9, 247- 257. https://doi.org/10.1007/s005200000214
  20. Potting, C. M. J., Blijlevens, N. A. M., Donnelly, J. P., Feuth, T., & Van Achterberg, T. (2006). A scoring system for the assessment of oral mucositis in daily nursing practice. European Journal of Cancer Care, 15, 228-234. https://doi.org/10.1111/j.1365-2354.2005.00644.x
  21. Quinn, B., Potting, C. M., Stone, R., Blijlevens, N. M., Fliedner, M., Margulies, A., et al. (2008). Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. European Journal of Cancer, 44, 61-72. https://doi.org/10.1016/j.ejca.2007.09.014
  22. Rogers, B. B. (2001). Mucositis in the oncology patient. Nursing Clinics of North America, 36, 745-760.
  23. Scully, C., Sonis, S., & Diz, P. D. (2006). Oral mucositis. Oral Diseases, 12, 229-241. https://doi.org/10.1111/j.1601-0825.2006.01258.x
  24. Sonis, S. T., Eilers, J. P., Epstein, J. B., LeVeque, F. G., Liggett, W. H., Jr, Mulagha, M. T. et al. (1999). Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer, 85, 2103-2113. https://doi.org/10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0
  25. Sonis, S. T., Elting, L. S., Keefe, D., Peterson, D. E., Schubert, M., Hauer-Jensen, M., et al. (2004). Perspectives on cancer therapyinduced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer, 100 (9Suppl), 1995S-2025S. https://doi.org/10.1002/cncr.20162
  26. Stiff, P. J., Emmanouilides, C., Bensinger, W. I., Gentile, T., Blazar, B., Shea, T. C., et al. (2006). Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting. Journal of Clinial Oncology, 24, 5186-5193. https://doi.org/10.1200/JCO.2005.02.8340
  27. Stiff, P. J., Erder, H., Bensinger, W. I., Emmanouilides, C., Gentile, T., Isitt, J. et al. (2006). Reliability and validity of a patient selfadministered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT). Bone Marrow Transplantation, 37, 393-401. https://doi.org/10.1038/sj.bmt.1705250
  28. Tomlinson, D., Judd, P., Hendershot, E., Maloney, A. M., & Sung, L. (2007). Measurement of oral mucositis in children: A review of the literature. Supportive Care in Cancer, 15, 1251-1258. https://doi.org/10.1007/s00520-007-0323-y
  29. Turhal, N. S., Erdal, S., & Karacay, S. (2000). Efficacy of treatment to relieve mucositis -induced discomfort. Supportive Care in Cancer, 8, 55-58.
  30. Wardley, A. M., Jayson, G. C., Swindell, R., Morgenstern, G. R., Chang, J., Bloor, R., et al. (2000). Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. British Journal of Haematology, 110, 292-299. https://doi.org/10.1046/j.1365-2141.2000.02202.x